2018 Vol.36, N°3 - Table of contents
May-June 2018
One year in review
CER11320
2018,36,3
Pg. 0347-0361
Free to view
One year in review 2018: novelties in the treatment of rheumatoid arthritis
A. Bortoluzzi, F. Furini, E. Generali, E. Silvagni, N. Luciano, C.A. Scirè
A. Bortoluzzi, F. Furini, E. Generali, E. Silvagni, N. Luciano, C.A. Scirè
Full Papers
CER10098
2018,36,3
Pg. 0362-0370
Free to view
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts
K. Britsemmer, D. Van Schaardenburg, M. Boers, D. De Cock, P. Verschueren, H. Radner, J.S. Smolen, L.H. Van Tuyl
K. Britsemmer, D. Van Schaardenburg, M. Boers, D. De Cock, P. Verschueren, H. Radner, J.S. Smolen, L.H. Van Tuyl
CER10595
2018,36,3
Pg. 0371-0375
Free to view
No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases
A. Forestier, D. Buob, T. Mirault, P. Puech, V. Gnemmi, D. Launay, E. Hachulla, P.-Y. Hatron, M. Lambert
A. Forestier, D. Buob, T. Mirault, P. Puech, V. Gnemmi, D. Launay, E. Hachulla, P.-Y. Hatron, M. Lambert
CER10564
2018,36,3
Pg. 0376-0381
Free to view
Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry
M. Bo, G.L. Erre, M. Niegowska, M. Piras, L. Taras, M.G. Longu, G. Passiu, L.A. Sechi
M. Bo, G.L. Erre, M. Niegowska, M. Piras, L. Taras, M.G. Longu, G. Passiu, L.A. Sechi
CER10574
2018,36,3
Pg. 0382-0388
Free to view
Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study
E. Toledano, A.M. Ortiz, J. Ivorra-Cortes, N. Montes, A. Beltran, L. Rodríguez-Rodriguez, L. Carmona, I. González-Álvaro
E. Toledano, A.M. Ortiz, J. Ivorra-Cortes, N. Montes, A. Beltran, L. Rodríguez-Rodriguez, L. Carmona, I. González-Álvaro
CER10484
2018,36,3
Pg. 0389-0395
Free to view
Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis
C.C. Mok, S.M. Tse, K.L. Chan, L.Y. Ho
C.C. Mok, S.M. Tse, K.L. Chan, L.Y. Ho
CER10399
2018,36,3
Pg. 0396-0404
Free to view
Effects and safety of 99Tc-MDP in patients with refractory ankylosing spondylitis: a 2-stage (30-week follow-up) clinical trial
Y. Xu, Y. Zhong, M. Zhao, L. Tu, M. Fan, P. Zhang, Q. Wei, S. Cao, Q. Li, Z. Liao, Z. Lin, Y. Pan, O. Jin, J. Gu
Y. Xu, Y. Zhong, M. Zhao, L. Tu, M. Fan, P. Zhang, Q. Wei, S. Cao, Q. Li, Z. Liao, Z. Lin, Y. Pan, O. Jin, J. Gu
CER10566
2018,36,3
Pg. 0405-0411
Free to view
Diagnostic value of BiP or anti-BiP antibodies for rheumatoid arthritis: a meta-analysis
Y. Liu, J. Wu, G. Shen, P. Lei
Y. Liu, J. Wu, G. Shen, P. Lei
CER10645
2018,36,3
Pg. 0412-0420
Free to view
Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis
S. Gunter, C. Robinson, A.J. Woodiwiss, G.R. Norton, H.-C. Hsu, A. Solomon, L. Tsang, A.M. Millen, P.H. Dessein
S. Gunter, C. Robinson, A.J. Woodiwiss, G.R. Norton, H.-C. Hsu, A. Solomon, L. Tsang, A.M. Millen, P.H. Dessein
CER10679
2018,36,3
Pg. 0421-0427
Free to view
Amylin in the insulin resistance of patients with rheumatoid arthritis
I. Ferraz-Amaro, R. López-Mejias, B. Tejera-Segura, A.M. De vera-González, B. Ubilla, J.M. Olmos, J.L. Hernández, M.A. González-Gay
I. Ferraz-Amaro, R. López-Mejias, B. Tejera-Segura, A.M. De vera-González, B. Ubilla, J.M. Olmos, J.L. Hernández, M.A. González-Gay
CER10619
2018,36,3
Pg. 0428-0433
Free to view
Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls
C. Lourdudoss, S. Ajeganova, J. Frostegård
C. Lourdudoss, S. Ajeganova, J. Frostegård
CER10261
2018,36,3
Pg. 0434-0441
Free to view
Association between perceived level of stress, clinical characteristics and psychopathological symptoms in women with systemic lupus erythematosus
M.I. Peralta-Ramírez, J.M. Pérez-Mármol, M. Castañeda-Cabestany, A.M. Santos-Ruiz, E. Montero-López, J.L. Callejas-Rubio, N. Navarrete-Navarrete, J.C. Fernández-Sánchez, J.F. Jiménez-Alonso, N. Ortego-Centeno, J.M. Sabio, M. García-Morales
M.I. Peralta-Ramírez, J.M. Pérez-Mármol, M. Castañeda-Cabestany, A.M. Santos-Ruiz, E. Montero-López, J.L. Callejas-Rubio, N. Navarrete-Navarrete, J.C. Fernández-Sánchez, J.F. Jiménez-Alonso, N. Ortego-Centeno, J.M. Sabio, M. García-Morales
CER10622
2018,36,3
Pg. 0442-0447
Free to view
Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis
Y. Zou, J. Du, Y. Zhu, X. Xie, J. Chen, G. Ling
Y. Zou, J. Du, Y. Zhu, X. Xie, J. Chen, G. Ling
CER10672
2018,36,3
Pg. 0448-0454
Free to view
Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept
A.S. Neubauer, C. Minartz, K.H. Herrmann, C.G. Baerwald
A.S. Neubauer, C. Minartz, K.H. Herrmann, C.G. Baerwald
CER10628
2018,36,3
Pg. 0455-0461
Free to view
Increased levels of serum histone H4 and activated protein C in patients with active rheumatoid arthritis
W. Peng, X. Liang, Y. Zhong, Y. Zhou, L. Hu, W. Wang
W. Peng, X. Liang, Y. Zhong, Y. Zhou, L. Hu, W. Wang
CER10426
2018,36,3
Pg. 0462-0470
Free to view
Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients
N.S. Gudmann, S. Hirata, M.A. Karsdal, S. Kubo, A.-C. Bay-Jensen, Y. Tanaka
N.S. Gudmann, S. Hirata, M.A. Karsdal, S. Kubo, A.-C. Bay-Jensen, Y. Tanaka
CER10597
2018,36,3
Pg. 0471-0478
Free to view
The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan
H.-W. Tseng, L.-Y. Lu, H.-C. Lam, K.-W. Tsai, W.-C. Huang, Y.-L. Shiue
H.-W. Tseng, L.-Y. Lu, H.-C. Lam, K.-W. Tsai, W.-C. Huang, Y.-L. Shiue
CER10659
2018,36,3
Pg. 0479-0485
Free to view
Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting
S. Iannazzo, M. Benucci, E.G. Favalli
S. Iannazzo, M. Benucci, E.G. Favalli
Brief Papers
CER10413
2018,36,3
Pg. 0486-0489
Free to view
Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis
F. Abji, R.A. Pollock, K. Liang, V. Chandran, D.D. Gladman
F. Abji, R.A. Pollock, K. Liang, V. Chandran, D.D. Gladman
CER10722
2018,36,3
Pg. 0490-0493
Free to view
Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases
G. Baulier, N. Issa, F. Gabriel, I. Accoceberry, F. Camou, P. Duffau
G. Baulier, N. Issa, F. Gabriel, I. Accoceberry, F. Camou, P. Duffau
Review
CER10952
2018,36,3
Pg. 0494-0501
Free to view
Chikungunya virus: a rheumatologist's perspective
M. Runowska, D. Majewski, K. Niklas, M. Puszczewicz
M. Runowska, D. Majewski, K. Niklas, M. Puszczewicz
Paediatric Rheumatology
CER10662
2018,36,3
Pg. 0502-0507
Free to view
Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study
P.H. Salonen, H. Säilä, J.H. Salonen, M. Linna, M. Helminen, M.J. Kauppi
P.H. Salonen, H. Säilä, J.H. Salonen, M. Linna, M. Helminen, M.J. Kauppi
CER10692
2018,36,3
Pg. 0508-0512
Free to view
The association of endothelial nitric oxide synthase gene single nucleotide polymorphisms with paediatric systemic lupus erythematosus
J. Zhu, Z. Wang, G. Song, T. Zhang, L. Wang, F. Wu
J. Zhu, Z. Wang, G. Song, T. Zhang, L. Wang, F. Wu
Letters to the Editor
CER10914
2018,36,3
Pg. 0513
Free to view
Does “time heal all wounds” still have a future in osteoarthritis?
J.H. Villafañe
J.H. Villafañe
CER10868
2018,36,3
Pg. 0514
Free to view
Dermoscopy as a supportive tool in differential diagnosis of psoriatic arthritis: another reason to include such a technique in rheumatology fellow curriculum
A. Zabotti, S. De Vita, G. Stinco, E. Errichetti
A. Zabotti, S. De Vita, G. Stinco, E. Errichetti
CER11009
2018,36,3
Pg. 0515-0516
Free to view
Löfgren syndrome as secondary autoimmune disease in a patient with B-cell depletion following rituximab treatment
A. Kronbichler, A.K. Luger, L. Loacker, A. Pizzini, J. Löffler-Ragg, I. Peschel
A. Kronbichler, A.K. Luger, L. Loacker, A. Pizzini, J. Löffler-Ragg, I. Peschel
CER10697
2018,36,3
Pg. 0517-0518
Free to view
Autoimmune or infectious disease? That is the question
C.A. Constantinou, G.E. Fragoulis, Η. Gakiopoulou, A.G. Tzioufas, N.V. Sipsas
C.A. Constantinou, G.E. Fragoulis, Η. Gakiopoulou, A.G. Tzioufas, N.V. Sipsas